On September 6, 2024, Elimelech Rosner, the Executive Vice President and Chief Technology Officer of HealthEquity Inc (HQY, Financial), sold 12,296 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 62,520 shares of HealthEquity Inc.
HealthEquity Inc (HQY, Financial) specializes in providing technology-enabled services platforms that facilitate consumer-directed health, wellness, and retirement savings accounts. The company is a leader in health savings accounts and offers a range of solutions for managing healthcare expenses.
Over the past year, Elimelech Rosner has engaged in multiple transactions involving the company's stock. The insider has sold a total of 16,311 shares and has not purchased any shares during this period. This recent sale is part of a broader trend observed at HealthEquity Inc, where there have been 21 insider sells and no insider buys over the past year.
On the day of the sale, shares of HealthEquity Inc were priced at $77.02. The company's market cap stood at approximately $6.522 billion. HealthEquity Inc's price-earnings ratio is currently 62.24, which is above the industry median of 23.62. This ratio is also lower than the company's historical median.
The stock's valuation according to GF Value is $81.94, indicating a price-to-GF-Value ratio of 0.94. This suggests that HealthEquity Inc is fairly valued based on the GF Value, which considers historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates.
The ongoing insider transactions and the current valuation metrics provide important data points for investors monitoring HealthEquity Inc's stock performance and insider behaviors.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
